Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases

Digestive and Liver Disease

Volumn 45, Issue 7, 2013, Pages 552-555

  Zorzi, Francesca ^a   Angelucci, Erika ^a   Sedda, Silvia ^a   Pallone, Francesco ^a   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Inflammatory bowel disease; Smad7

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GAMMA INTERFERON; GED 0301; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; OXAZOLONE; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTISENSE THERAPY; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; ENZYME INHIBITION; HUMAN; MOUSE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

EID: 84881260209     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.11.011     Document Type: Article

References (32)

1. Podolsky D.K. Inflammatory bowel disease. New England Journal of Medicine 2002, 347:417-429.
2. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
3. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
4. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nature Reviews Immunology 2003, 3:521-533.
5. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. Journal of Clinical Investigation 2007, 117:514-521.
6. Kulkarni A.B., Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. American Journal of Pathology 1993, 143:3-9.
7. Gorelik L., Flavel R.A. Transforming growth factor β in T cell biology. Nature Reviews Immunology 2002, 2:46-53.
8. Neurath M.F., Fuss I., Kelsall B.L., et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. Journal of Experimental Medicine 1996, 183:2605-2616.
9. Boirivant M., Fuss I.J., Chu A., et al. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. Journal of Experimental Medicine 1998, 188:1929-1939.
10. Powrie F., Carlino J., Leach M.W., et al. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. Journal of Experimental Medicine 1996, 183:2669-2674.
11. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
12. Heldin C.H., Kohei M., Ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
13. Yang X., Letterio J.J., Lechleider R.J., et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO Journal 1999, 18:1280-1291.
14. Di Sabatino A., Pickard K.M., Rampton D., et al. Blockade of transforming growth factor beta upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut 2008, 57:605-612.
15. Monteleone G., Kumberova A., Croft N.M., et al. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. Journal of Clinical Investigation 2001, 108:601-609.
16. Babyatsky M.W., Rossiter G., Podolsky D.K. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996, 110:975-984.
17. Monteleone G., Mann J., Monteleone I., et al. A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. Journal of Biological Chemistry 2004, 279:3925-3932.
18. Nakao A., Afrakhte M., Morén A., et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF betasignalling. Nature 1997, 389:631-635.
19. Shi W., Sun C., He B., et al. GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. Journal of Cell Biology 2004, 164:291-300.
20. Monteleone G., Del Vecchio Blanco G., Palmieri G., et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology 2004, 126:674-682.
21. Benahmed M., Meresse B., Arnulf B., et al. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007, 132:994-1008.
22. Neurath M.F., Fuss I., Kelsal B.L., et al. Antibodies to IL-12 abrogate established experimental colitis in mice. Journal of Experimental Medicine 1995, 182:1281-1289.
23. Boirivant M., Pallone F., Di Giacinto C Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Gastroenterology 2006, 131:1786-1798.
24. Monteleone G., Boirivant M., Pallone F., et al. TGF-beta1 and Smad7 in the regulation of IBD. Mucosal Immunology 2008, 1(Suppl. 1):S50-S53.
25. Monteleone G., Fantini M.C., Onali S., et al. Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease. Molecular Therapy 2012, 20:870-876.
26. Saruta M., Yu Q.T., Avanesyan A., et al. Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease. Journal of Immunology 2007, 178:3293-3300.
27. Zorzi F., Calabrese E., Monteleone I., et al. A phase 1 open-label trial shows that Smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease. Alimentary Pharmacology and Therapeutics 2012, [Epub ahead of print].
28. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-β. Annual Review of Immunology 1998, 16:137-161.
29. Monteleone G., Pallone F., MacDonald T.T. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends in Immunology 2004, 25:513-517.
30. Leask A., Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB Journal 2004, 18:816-827.
31. Verrecchia F., Mauviel A. Transforming growth factor-beta and fibrosis. World Journal of Gastroenterology 2007, 13:3056-3062.
32. Rizzo A., Waldner M.J., Stolfi C., et al. Smad7 expression in T cells prevents colitis-associated cancer. Cancer Research 2011, 71:7423-7432.